|
ERNAW Ernexa Therapeutics Inc 748592 |
| Balance Sheet |
|
Current Assets
|
$9,996,000.00 |
|
Assets
|
$10,543,000.00 |
|
Current Liabilities
|
$3,457,000.00 |
|
Liabilities
|
$3,684,000.00 |
|
Equity
|
$6,859,000.00 |
|
Shares Out
|
1166000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,264,000.00 |
|
Investing Cash Flow
|
$-2,000.00 |
| Market Analysis |
Market Cap
|
$46,640.00 |
|
Price
|
$0.04 |
|
BVPS
|
5.88 |
|
PB
|
0.01 |
|
EPS
|
-6.95 |
|
PS
|
0.08 |
|
FCF
|
$-2,266,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:32:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:10 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ERNAW documents filed with the SEC.
ERNAW Filings
Clear
